The global healthcare contract research organization market size is expected to reach USD 80.5 billion by 2030 and is projected to expand at a CAGR of 7.8% from 2023 to 2030, according to this report. The increasing cost of drug development is expected to drive market demand over the forecast period. Also, rising clinical trials cost and challenges pertaining to patient recruitment have led biopharmaceutical companies to turn to regions like Central and Eastern Europe, Asia Pacific, Latin America, and the Middle East for cost savings and quick patient recruitment. ![Global Healthcare Contract Research Organization Market]( "Global Healthcare Contract Research Organization Market")
In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations(CRO)s. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.
The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.
Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences’ access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies’ services space. Hence, the aforementioned factors supported the market’s growth.
This product will be delivered within 1-3 business days.
In addition, growing pressure on industry players to follow stringent timelines has increased the demand for outsourcing research activities to contract research organizations(CRO)s. Some government organizations are also outsourcing their clinical trial activities so that they can carry out clinical trials with the required infrastructure and expertise and minimize their cost and timelines.
The CRO market was temporarily affected by the ongoing pandemic, as it led to the closure of clinical trial sites. However, owing to the significant demand for treatments, the clinical trial sites were reopened with certain measures and precautions to avoid the spread of the virus. Moreover, the worldwide focus on finding a vaccine against coronavirus has had a significant impact on the development of vaccines & drugs for COVID-19. This is expected to have a positive impact on the market.
Over the past 5 years, the number of mergers and acquisitions significantly increased. Several large mergers have been witnessed since 2016 till 2023. Moreover, the trend of large transactions seems to be picking up since 2021, as in March 2022, M&B Sciences Inc, acquired Clara Health, which expanded M&B Sciences’ access to digital technology-based clinical trials. Moreover, in December 2021, Thermo Fisher announced the acquisition of pharmaceutical services giant PPD, and in February 2021, ICON plc announced the acquisition of PRA Health Sciences. An era of consolidation has been witnessed around analytical technologies and software solutions used in the biopharmaceutical and pharmaceutical companies’ services space. Hence, the aforementioned factors supported the market’s growth.
Healthcare Contract Research Organization Market Report Highlights
- Based on type, the clinical segment has dominated the global healthcare CRO market in 2022, with the largest share of 76.2% owing to the fact that it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment
- Among services, the clinical monitoring segment was the largest in terms of market share at 20.2% in 2022
- North America held a significant market share of 24.8% in 2022 due to the presence of several global players who invest a major part of their revenue in research activities
- Asia Pacific is anticipated to witness lucrative growth of 9.5% over the forecast period due to the reduced cost it offers in comparison to the western economies
- China, Japan, and India are projected to witness tremendous growth in the contract research organization market owing to high disease prevalence
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology And Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. Service
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
1.1.1. Segment Definitions
1.1.2. Type
1.1.3. Service
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective-1
1.4.2. Objective-2
1.4.3. Objective-3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.9.2. Parent Market Analysis
1.10. List Of Secondary Sources
1.11. List Of Abbreviations
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Healthcare Contract Research Organization Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Rate of Clinical Research To Boost Demand For Outsourcing Services
3.2.1.2. Increasing Adoption Of Advanced Technologies
3.2.1.3. Increasing Mergers and Collaborations
3.2.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
3.2.1.5. Patent Cliff
3.2.2. Market Restraint Analysis
3.2.2.1. Quality issues of CRO services
3.2.2.2. Intellectual property rights issues
3.3. Healthcare Contract Research Organization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Rate of Clinical Research To Boost Demand For Outsourcing Services
3.2.1.2. Increasing Adoption Of Advanced Technologies
3.2.1.3. Increasing Mergers and Collaborations
3.2.1.4. Increasing Demand For Outsourcing Services Across The Developing Economies
3.2.1.5. Patent Cliff
3.2.2. Market Restraint Analysis
3.2.2.1. Quality issues of CRO services
3.2.2.2. Intellectual property rights issues
3.3. Healthcare Contract Research Organization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat Of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Healthcare Contract Research Organization Market: Type Estimates & Trend Analysis
4.1. Healthcare Contract Research Organization Market, By Type: Segment Dashboard
4.2. Healthcare Contract Research Organization Market, By Type: Movement Analysis
4.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Drug Discovery
4.3.1.1. Drug Discovery Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.2. Target Validation
4.3.1.2.1. Target Validation Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.3. Lead Identification
4.3.1.3.1. Lead Identification Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.4. Lead Optimization
4.3.1.4.1. Lead Optimization Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.2. Pre-clinical
4.3.2.1. Pre-clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3. Clinical
4.3.3.1. Clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.2. Phase I Trial Services
4.3.3.2.1. Phase I Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.3. Phase II Trial Services
4.3.3.3.1. Phase II Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.4. Phase III Trial Services
4.3.3.4.1. Phase III Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.5. Phase IV Trial Services
4.3.3.5.1. Phase IV Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.2. Healthcare Contract Research Organization Market, By Type: Movement Analysis
4.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Type, 2018 - 2030
4.3.1. Drug Discovery
4.3.1.1. Drug Discovery Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.2. Target Validation
4.3.1.2.1. Target Validation Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.3. Lead Identification
4.3.1.3.1. Lead Identification Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.1.4. Lead Optimization
4.3.1.4.1. Lead Optimization Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.2. Pre-clinical
4.3.2.1. Pre-clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3. Clinical
4.3.3.1. Clinical Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.2. Phase I Trial Services
4.3.3.2.1. Phase I Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.3. Phase II Trial Services
4.3.3.3.1. Phase II Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.4. Phase III Trial Services
4.3.3.4.1. Phase III Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
4.3.3.5. Phase IV Trial Services
4.3.3.5.1. Phase IV Trial Services Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
Chapter 5. Healthcare Contract Research Organization Market: Services Estimates & Trend Analysis
5.1. Healthcare Contract Research Organization Market, By Services: Segment Dashboard
5.2. Healthcare Contract Research Organization Market, By Services: Movement Analysis
5.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Services, 2018 - 2030
5.3.1. Project Management/Clinical Supply Management
5.3.1.1. Project Management/Clinical Supply Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.2. Data Management
5.3.2.1. Data Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.3. Regulatory/Medical Affairs
5.3.3.1. Regulatory/Medical Affairs Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.4. Medical Writing
5.3.4.1. Medical Writing Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.5. Clinical Monitoring
5.3.5.1. Clinical Monitoring Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.6. Quality Management/Assurance
5.3.6.1. Quality Management/Assurance Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.7. Bio-statistics
5.3.7.1. Bio-statistics Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.8. Investigator Payments
5.3.8.1. Investigator Payments Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.9. Laboratory
5.3.9.1. Laboratory Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.10. Patient and Site Recruitment
5.3.10.1. Patient and Site Recruitment Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.11. Technology
5.3.11.1. Technology Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.12. Others
5.3.12.1. Others Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.2. Healthcare Contract Research Organization Market, By Services: Movement Analysis
5.3. Healthcare Contract Research Organization Market Estimates & Forecasts, By Services, 2018 - 2030
5.3.1. Project Management/Clinical Supply Management
5.3.1.1. Project Management/Clinical Supply Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.2. Data Management
5.3.2.1. Data Management Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.3. Regulatory/Medical Affairs
5.3.3.1. Regulatory/Medical Affairs Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.4. Medical Writing
5.3.4.1. Medical Writing Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.5. Clinical Monitoring
5.3.5.1. Clinical Monitoring Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.6. Quality Management/Assurance
5.3.6.1. Quality Management/Assurance Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.7. Bio-statistics
5.3.7.1. Bio-statistics Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.8. Investigator Payments
5.3.8.1. Investigator Payments Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.9. Laboratory
5.3.9.1. Laboratory Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.10. Patient and Site Recruitment
5.3.10.1. Patient and Site Recruitment Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.11. Technology
5.3.11.1. Technology Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
5.3.12. Others
5.3.12.1. Others Healthcare Contract Research Organization Market, 2018 to 2030 (USD Million)
Chapter 6. Healthcare Contract Research Organization Market: Regional Estimates & Trend Analysis
6.1. Regional Market Share Analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Switzerland
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
6.5.7. Belgium
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Belgium Market Estimates and Forecasts, 2018 - 2030
6.5.8. Netherlands
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.5.9. Austria
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Austria Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.6.7. Taiwan
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Taiwan Market Estimates and Forecasts, 2018 - 2030
6.6.8. Indonesia
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Indonesia Market Estimates and Forecasts, 2018 - 2030
6.6.9. Malaysia
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
6.6.10. Singapore
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. Middle East & North Africa
6.8.1. Egypt
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. Egypt Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Iran
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Iran Market Estimates and Forecasts, 2018 - 2030
6.8.5. Israel
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
6.9. Rest of the World
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory Framework
6.9.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. North America
6.4.1. Market Estimates and Forecast, 2018 - 2030 (Revenue, USD Million)
6.4.2. U.S.
6.4.2.1. Key Country Dynamics
6.4.2.2. Competitive Scenario
6.4.2.3. Regulatory Framework
6.4.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030
6.4.3. Canada
6.4.3.1. Key Country Dynamics
6.4.3.2. Competitive Scenario
6.4.3.3. Regulatory Framework
6.4.3.4. Canada Market Estimates and Forecasts, 2018 - 2030
6.5. Europe
6.5.1. UK
6.5.1.1. Key Country Dynamics
6.5.1.2. Competitive Scenario
6.5.1.3. Regulatory Framework
6.5.1.4. UK Market Estimates and Forecasts, 2018 - 2030
6.5.2. Germany
6.5.2.1. Key Country Dynamics
6.5.2.2. Competitive Scenario
6.5.2.3. Regulatory Framework
6.5.2.4. Germany Market Estimates and Forecasts, 2018 - 2030
6.5.3. France
6.5.3.1. Key Country Dynamics
6.5.3.2. Competitive Scenario
6.5.3.3. Regulatory Framework
6.5.3.4. France Market Estimates and Forecasts, 2018 - 2030
6.5.4. Italy
6.5.4.1. Key Country Dynamics
6.5.4.2. Competitive Scenario
6.5.4.3. Regulatory Framework
6.5.4.4. Italy Market Estimates and Forecasts, 2018 - 2030
6.5.5. Spain
6.5.5.1. Key Country Dynamics
6.5.5.2. Competitive Scenario
6.5.5.3. Regulatory Framework
6.5.5.4. Spain Market Estimates and Forecasts, 2018 - 2030
6.5.6. Switzerland
6.5.6.1. Key Country Dynamics
6.5.6.2. Competitive Scenario
6.5.6.3. Regulatory Framework
6.5.6.4. Switzerland Market Estimates and Forecasts, 2018 - 2030
6.5.7. Belgium
6.5.7.1. Key Country Dynamics
6.5.7.2. Competitive Scenario
6.5.7.3. Regulatory Framework
6.5.7.4. Belgium Market Estimates and Forecasts, 2018 - 2030
6.5.8. Netherlands
6.5.8.1. Key Country Dynamics
6.5.8.2. Competitive Scenario
6.5.8.3. Regulatory Framework
6.5.8.4. Netherlands Market Estimates and Forecasts, 2018 - 2030
6.5.9. Austria
6.5.9.1. Key Country Dynamics
6.5.9.2. Competitive Scenario
6.5.9.3. Regulatory Framework
6.5.9.4. Austria Market Estimates and Forecasts, 2018 - 2030
6.6. Asia Pacific
6.6.1. Japan
6.6.1.1. Key Country Dynamics
6.6.1.2. Competitive Scenario
6.6.1.3. Regulatory Framework
6.6.1.4. Japan Market Estimates and Forecasts, 2018 - 2030
6.6.2. India
6.6.2.1. Key Country Dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory Framework
6.6.2.4. India Market Estimates and Forecasts, 2018 - 2030
6.6.3. China
6.6.3.1. Key Country Dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory Framework
6.6.3.4. China Market Estimates and Forecasts, 2018 - 2030
6.6.4. South Korea
6.6.4.1. Key Country Dynamics
6.6.4.2. Competitive Scenario
6.6.4.3. Regulatory Framework
6.6.4.4. South Korea Market Estimates and Forecasts, 2018 - 2030
6.6.5. Australia
6.6.5.1. Key Country Dynamics
6.6.5.2. Competitive Scenario
6.6.5.3. Regulatory Framework
6.6.5.4. Australia Market Estimates and Forecasts, 2018 - 2030
6.6.6. Thailand
6.6.6.1. Key Country Dynamics
6.6.6.2. Competitive Scenario
6.6.6.3. Regulatory Framework
6.6.6.4. Thailand Market Estimates and Forecasts, 2018 - 2030
6.6.7. Taiwan
6.6.7.1. Key Country Dynamics
6.6.7.2. Competitive Scenario
6.6.7.3. Regulatory Framework
6.6.7.4. Taiwan Market Estimates and Forecasts, 2018 - 2030
6.6.8. Indonesia
6.6.8.1. Key Country Dynamics
6.6.8.2. Competitive Scenario
6.6.8.3. Regulatory Framework
6.6.8.4. Indonesia Market Estimates and Forecasts, 2018 - 2030
6.6.9. Malaysia
6.6.9.1. Key Country Dynamics
6.6.9.2. Competitive Scenario
6.6.9.3. Regulatory Framework
6.6.9.4. Malaysia Market Estimates and Forecasts, 2018 - 2030
6.6.10. Singapore
6.6.10.1. Key Country Dynamics
6.6.10.2. Competitive Scenario
6.6.10.3. Regulatory Framework
6.6.10.4. Singapore Market Estimates and Forecasts, 2018 - 2030
6.7. Latin America
6.7.1. Brazil
6.7.1.1. Key Country Dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory Framework
6.7.1.4. Brazil Market Estimates and Forecasts, 2018 - 2030
6.7.2. Mexico
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory Framework
6.7.2.4. Mexico Market Estimates and Forecasts, 2018 - 2030
6.7.3. Argentina
6.7.3.1. Key Country Dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory Framework
6.7.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030
6.7.4. Colombia
6.7.4.1. Key Country Dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory Framework
6.7.4.4. Colombia Market Estimates and Forecasts, 2018 - 2030
6.7.5. Chile
6.7.5.1. Key Country Dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory Framework
6.7.5.4. Chile Market Estimates and Forecasts, 2018 - 2030
6.8. Middle East & North Africa
6.8.1. Egypt
6.8.1.1. Key Country Dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory Framework
6.8.1.4. Egypt Market Estimates and Forecasts, 2018 - 2030
6.8.2. Saudi Arabia
6.8.2.1. Key Country Dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory Framework
6.8.2.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
6.8.3. UAE
6.8.3.1. Key Country Dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory Framework
6.8.3.4. UAE Market Estimates and Forecasts, 2018 - 2030
6.8.4. Iran
6.8.4.1. Key Country Dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory Framework
6.8.4.4. Iran Market Estimates and Forecasts, 2018 - 2030
6.8.5. Israel
6.8.5.1. Key Country Dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory Framework
6.8.5.4. Israel Market Estimates and Forecasts, 2018 - 2030
6.9. Rest of the World
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory Framework
6.9.1.4. South Africa Market Estimates and Forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Market Participant Categorization
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1. ICON Plc
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Charles River Laboratories
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Syneos Health
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. IQVIA Inc
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. GVK Biosciences Private Limited
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Laboratory Corporation of America Holdings
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Thermo Fisher Scientific Inc.
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Parexel International Corporation
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. Medidata Solutions, Inc
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. Pharmaron GMBH.
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. SGS SA
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
7.2.12. KCR S.A.
7.2.12.1. Company Overview
7.2.12.2. Financial Performance
7.2.12.3. Service Benchmarking
7.2.12.4. Strategic Initiatives
7.2.13. CTI Clinical Trial & Consulting
7.2.13.1. Company Overview
7.2.13.2. Financial Performance
7.2.13.3. Service Benchmarking
7.2.13.4. Strategic Initiatives
7.2.14. PSI
7.2.14.1. Company Overview
7.2.14.2. Financial Performance
7.2.14.3. Service Benchmarking
7.2.14.4. Strategic Initiatives
7.2.15. Worldwide Clinical Trials
7.2.15.1. Company Overview
7.2.15.2. Financial Performance
7.2.15.3. Service Benchmarking
7.2.15.4. Strategic Initiatives
7.2.16. Wuxi AppTec
7.2.16.1. Company Overview
7.2.16.2. Financial Performance
7.2.16.3. Service Benchmarking
7.2.16.4. Strategic Initiatives
7.2.17. Advanced Clinical
7.2.17.1. Company Overview
7.2.17.2. Financial Performance
7.2.17.3. Service Benchmarking
7.2.17.4. Strategic Initiatives
7.2.18. Caidya
7.2.18.1. Company Overview
7.2.18.2. Financial Performance
7.2.18.3. Service Benchmarking
7.2.18.4. Strategic Initiatives
7.1.1. Innovators
7.1.2. Market Leaders
7.1.3. Emerging Players
7.1.4. Company Market Share Analysis, 2022
7.2. Company Profiles
7.2.1. ICON Plc
7.2.1.1. Company Overview
7.2.1.2. Financial Performance
7.2.1.3. Service Benchmarking
7.2.1.4. Strategic Initiatives
7.2.2. Charles River Laboratories
7.2.2.1. Company Overview
7.2.2.2. Financial Performance
7.2.2.3. Service Benchmarking
7.2.2.4. Strategic Initiatives
7.2.3. Syneos Health
7.2.3.1. Company Overview
7.2.3.2. Financial Performance
7.2.3.3. Service Benchmarking
7.2.3.4. Strategic Initiatives
7.2.4. IQVIA Inc
7.2.4.1. Company Overview
7.2.4.2. Financial Performance
7.2.4.3. Service Benchmarking
7.2.4.4. Strategic Initiatives
7.2.5. GVK Biosciences Private Limited
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Service Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Laboratory Corporation of America Holdings
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Service Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. Thermo Fisher Scientific Inc.
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Service Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. Parexel International Corporation
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Service Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. Medidata Solutions, Inc
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Service Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. Pharmaron GMBH.
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Service Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. SGS SA
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Service Benchmarking
7.2.11.4. Strategic Initiatives
7.2.12. KCR S.A.
7.2.12.1. Company Overview
7.2.12.2. Financial Performance
7.2.12.3. Service Benchmarking
7.2.12.4. Strategic Initiatives
7.2.13. CTI Clinical Trial & Consulting
7.2.13.1. Company Overview
7.2.13.2. Financial Performance
7.2.13.3. Service Benchmarking
7.2.13.4. Strategic Initiatives
7.2.14. PSI
7.2.14.1. Company Overview
7.2.14.2. Financial Performance
7.2.14.3. Service Benchmarking
7.2.14.4. Strategic Initiatives
7.2.15. Worldwide Clinical Trials
7.2.15.1. Company Overview
7.2.15.2. Financial Performance
7.2.15.3. Service Benchmarking
7.2.15.4. Strategic Initiatives
7.2.16. Wuxi AppTec
7.2.16.1. Company Overview
7.2.16.2. Financial Performance
7.2.16.3. Service Benchmarking
7.2.16.4. Strategic Initiatives
7.2.17. Advanced Clinical
7.2.17.1. Company Overview
7.2.17.2. Financial Performance
7.2.17.3. Service Benchmarking
7.2.17.4. Strategic Initiatives
7.2.18. Caidya
7.2.18.1. Company Overview
7.2.18.2. Financial Performance
7.2.18.3. Service Benchmarking
7.2.18.4. Strategic Initiatives
List of Tables
Table 1: List of Secondary Sources
Table 2: List of Abbreviations
Table 3: Global Healthcare Contract Research Outsourcing Market, by Region, 2018-2030 (USD Million)
Table 4: Global Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 5: Global Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 6: Global Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 7: Global Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 8: North America Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 9: North America Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 10: North America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 11: North America Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 12: North America Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 13: U.S. Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 14: U.S. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 15: U.S. Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 16: U.S. Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 17: Canada Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 18: Canada Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 19: Canada Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 20: Canada Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 21: Europe Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 22: Europe Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 23: Europe Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 24: Europe Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 25: Europe Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 26: UK Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 27: UK Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 28: UK Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 29: UK Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 30: Germany Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 31: Germany Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 32: Germany Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 33: Germany Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 34: France Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 35: France Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 36: France Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 37: France Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 38: Italy Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 39: Italy Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 40: Italy Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 41: Italy Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 42: Spain Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 43: Spain Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 44: Spain Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 45: Spain Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 46: Switzerland Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 47: Switzerland Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 48: Switzerland Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 49: Switzerland Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 50: Belgium Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 51: Belgium Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 52: Belgium Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 53: Belgium Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 54: Netherlands Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 55: Netherlands Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 56: Netherlands Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 57: Netherlands Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 58: Austria Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 59: Austria Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 60: Austria Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 61: Austria Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 62: Asia Pacific Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 63: Asia Pacific Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 64: Asia Pacific Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 65: Asia Pacific Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 66: Asia Pacific Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 67: India Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 68: India Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 69: India Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 70: India Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 71: China Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 72: China Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 73: China Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 74: China Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 75: Japan Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 76: Japan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 77: Japan Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 78: Japan Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 79: South Korea Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 80: South Korea Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 81: South Korea Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 82: South Korea Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 83: Taiwan Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 84: Taiwan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 85: Taiwan Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 86: Taiwan Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 87: Australia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 88: Australia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 89: Australia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 90: Australia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 91: Indonesia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 92: Indonesia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 93: Indonesia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 94: Indonesia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 95: Malaysia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 96: Malaysia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 97: Malaysia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 98: Malaysia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 99: Singapore Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 100: Singapore Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 101: Singapore Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 102: Singapore Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 103: Thailand Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 104: Thailand Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 105: Thailand Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 106: Thailand Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 107: Latin America Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 108: Latin America Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 109: Latin America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 110: Latin America Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 111: Latin America Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 112: Brazil Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 113: Brazil Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 114: Brazil Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 115: Brazil Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 116: Mexico Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 117: Mexico Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 118: Mexico Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 119: Mexico Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 120: Argentina Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 121: Argentina Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 122: Argentina Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 123: Argentina Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 124: Colombia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 125: Colombia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 126: Colombia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 127: Colombia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 128: Chile Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 129: Chile Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 130: Chile Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 131: Chile Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 132: MEA Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 133: MEA Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 134: MEA Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 135: MEA Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 136: MEA Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 137: Egypt Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 138: Egypt Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 139: Egypt Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 140: Egypt Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 141: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 142: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 143: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 144: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 145: UAE Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 146: UAE Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 147: UAE Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 148: UAE Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 149: Iran Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 150: Iran Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 151: Iran Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 152: Iran Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 153: Israel Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 154: Israel Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 155: Israel Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 156: Rest Of The World Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 157: Rest Of The World Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 158: Rest Of The World Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 159: Rest Of The World Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 160: Rest Of The World Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 161: South Africa Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 162: South Africa Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 163: South Africa Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 164: South Africa Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 2: List of Abbreviations
Table 3: Global Healthcare Contract Research Outsourcing Market, by Region, 2018-2030 (USD Million)
Table 4: Global Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 5: Global Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 6: Global Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 7: Global Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 8: North America Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 9: North America Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 10: North America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 11: North America Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 12: North America Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 13: U.S. Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 14: U.S. Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 15: U.S. Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 16: U.S. Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 17: Canada Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 18: Canada Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 19: Canada Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 20: Canada Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 21: Europe Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 22: Europe Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 23: Europe Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 24: Europe Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 25: Europe Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 26: UK Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 27: UK Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 28: UK Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 29: UK Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 30: Germany Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 31: Germany Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 32: Germany Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 33: Germany Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 34: France Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 35: France Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 36: France Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 37: France Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 38: Italy Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 39: Italy Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 40: Italy Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 41: Italy Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 42: Spain Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 43: Spain Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 44: Spain Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 45: Spain Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 46: Switzerland Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 47: Switzerland Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 48: Switzerland Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 49: Switzerland Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 50: Belgium Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 51: Belgium Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 52: Belgium Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 53: Belgium Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 54: Netherlands Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 55: Netherlands Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 56: Netherlands Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 57: Netherlands Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 58: Austria Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 59: Austria Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 60: Austria Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 61: Austria Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 62: Asia Pacific Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 63: Asia Pacific Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 64: Asia Pacific Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 65: Asia Pacific Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 66: Asia Pacific Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 67: India Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 68: India Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 69: India Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 70: India Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 71: China Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 72: China Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 73: China Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 74: China Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 75: Japan Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 76: Japan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 77: Japan Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 78: Japan Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 79: South Korea Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 80: South Korea Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 81: South Korea Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 82: South Korea Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 83: Taiwan Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 84: Taiwan Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 85: Taiwan Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 86: Taiwan Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 87: Australia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 88: Australia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 89: Australia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 90: Australia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 91: Indonesia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 92: Indonesia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 93: Indonesia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 94: Indonesia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 95: Malaysia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 96: Malaysia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 97: Malaysia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 98: Malaysia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 99: Singapore Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 100: Singapore Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 101: Singapore Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 102: Singapore Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 103: Thailand Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 104: Thailand Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 105: Thailand Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 106: Thailand Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 107: Latin America Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 108: Latin America Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 109: Latin America Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 110: Latin America Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 111: Latin America Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 112: Brazil Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 113: Brazil Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 114: Brazil Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 115: Brazil Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 116: Mexico Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 117: Mexico Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 118: Mexico Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 119: Mexico Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 120: Argentina Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 121: Argentina Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 122: Argentina Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 123: Argentina Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 124: Colombia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 125: Colombia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 126: Colombia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 127: Colombia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 128: Chile Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 129: Chile Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 130: Chile Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 131: Chile Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 132: MEA Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 133: MEA Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 134: MEA Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 135: MEA Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 136: MEA Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 137: Egypt Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 138: Egypt Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 139: Egypt Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 140: Egypt Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 141: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 142: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 143: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 144: Saudi Arabia Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 145: UAE Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 146: UAE Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 147: UAE Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 148: UAE Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 149: Iran Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 150: Iran Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 151: Iran Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 152: Iran Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 153: Israel Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 154: Israel Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 155: Israel Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 156: Rest Of The World Healthcare Contract Research Outsourcing Market, by Country, 2018-2030 (USD Million)
Table 157: Rest Of The World Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 158: Rest Of The World Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 159: Rest Of The World Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 160: Rest Of The World Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
Table 161: South Africa Healthcare Contract Research Outsourcing Market, by Type, 2018-2030 (USD Million)
Table 162: South Africa Healthcare Contract Research Outsourcing Market, by Drug Discovery, 2018-2030 (USD Million)
Table 163: South Africa Healthcare Contract Research Outsourcing Market, by Clinical, 2018-2030 (USD Million)
Table 164: South Africa Healthcare Contract Research Outsourcing Market, by Service, 2018-2030 (USD Million)
List of Figures
Fig. 1: Market research process
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value-chain-based sizing & forecasting
Fig. 6: QFD modeling for market share assessment
Fig. 7: Market formulation & validation
Fig. 8: Commodity Flow Analysis
Fig. 9: Parent Market Analysis
Fig. 10: Healthcare CRO market snapshot (2022)
Fig. 11: Market trends and outlook
Fig. 12: Healthcare CRO market segmentation
Fig. 13: Market driver relevance analysis (Current & future impact)
Fig. 14: Benefits of using robotic labs
Fig. 15: Pharmaceutical R&D spending 2020-2022 (USD Billion)
Fig. 16: Market restraint relevance analysis (Current & future impact)
Fig. 17: Penetration & growth prospect mapping
Fig. 18: Porter’s five forces analysis
Fig. 19: SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20: Healthcare CRO market stage outlook: Segment dashboard
Fig. 21: Healthcare CRO market: Type movement analysis
Fig. 22: Drug discovery market, 2018-2030 (USD Million)
Fig. 23: Target validation market, 2018-2030 (USD Million)
Fig. 24: Lead identification market, 2018-2030 (USD Million)
Fig. 25: Lead optimization market, 2018-2030 (USD Million)
Fig. 26: Pre-clinical market, 2018-2030 (USD Million)
Fig. 27: Clinical market, 2018-2030 (USD Million)
Fig. 28: Phase I trial services market, 2018-2030 (USD Million)
Fig. 29: Phase II trial services market, 2018-2030 (USD Million)
Fig. 30: Phase III trial services market, 2018-2030 (USD Million)
Fig. 31: Phase IV trial services market, 2018-2030 (USD Million)
Fig. 32: Healthcare CRO market Service outlook: Segment dashboard
Fig. 33: Healthcare CRO market: Service movement analysis
Fig. 34: Parameters for measuring success of provider solution
Fig. 35: Project management/clinical supply management market, 2018-2030 (USD Million)
Fig. 36: Clinical data management flow
Fig. 37: Data management market, 2018-2030 (USD Million)
Fig. 38: Regulatory/medical affairs market, 2018-2030 (USD Million)
Fig. 39: Medical writing market, 2018-2030 (USD Million)
Fig. 40: Clinical monitoring market, 2018-2030 (USD Million)
Fig. 41: Quality management/ assurance market, 2018-2030 (USD Million)
Fig. 42: Bio-statistics market, 2018-2030 (USD Million)
Fig. 43: Investigator payments market, 2018-2030 (USD Million)
Fig. 44: Laboratory market, 2018-2030 (USD Million)
Fig. 45: Strategic initiatives with positive impact on patient recruitment
Fig. 46: Patient and site recruitment market, 2018-2030 (USD Million)
Fig. 47: Technology services market, 2018-2030 (USD Million)
Fig. 48: Other services market, 2018-2030 (USD Million)
Fig. 49: Regional market: Key takeaways
Fig. 50: Regional outlook, 2022 & 2030
Fig. 51: North America market, 2018-2030 (USD Million)
Fig. 52: U.S. market, 2018-2030 (USD Million)
Fig. 53: Canada market, 2018-2030 (USD Million)
Fig. 54: Europe market, 2018-2030 (USD Million)
Fig. 55: UK market, 2018-2030 (USD Million)
Fig. 56: Germany market, 2018-2030 (USD Million)
Fig. 57: France market, 2018-2030 (USD Million)
Fig. 58: Italy market, 2018-2030 (USD Million)
Fig. 59: Spain market, 2018-2030 (USD Million)
Fig. 60: Switzerland market, 2018-2030 (USD Million)
Fig. 61: Belgium market, 2018-2030 (USD Million)
Fig. 62: Netherlands market, 2018-2030 (USD Million)
Fig. 63: Austria market, 2018-2030 (USD Million)
Fig. 64: Asia Pacific market, 2018-2030 (USD Million)
Fig. 65: India market, 2018-2030 (USD Million)
Fig. 66: China market, 2018-2030 (USD Million)
Fig. 67: Japan market, 2018-2030 (USD Million)
Fig. 68: South Korea market, 2018-2030 (USD Million)
Fig. 69: Taiwan market, 2018-2030 (USD Million)
Fig. 70: Australia market, 2018-2030 (USD Million)
Fig. 71: Indonesia market, 2018-2030 (USD Million)
Fig. 72: Malaysia market, 2018-2030 (USD Million)
Fig. 73: Singapore market, 2018-2030 (USD Million)
Fig. 74: Thailand market, 2018-2030 (USD Million)
Fig. 75: Latin America market, 2018-2030 (USD Million)
Fig. 76: Brazil market, 2018-2030 (USD Million)
Fig. 77: Mexico market, 2018-2030 (USD Million)
Fig. 78: Argentina market, 2018-2030 (USD Million)
Fig. 79: Colombia market, 2018-2030 (USD Million)
Fig. 80: Chile market, 2018-2030 (USD Million)
Fig. 81: Middle East & North Africa market, 2018-2030 (USD Million)
Fig. 82: Egypt market, 2018-2030 (USD Million)
Fig. 83: Saudi Arabia market, 2018-2030 (USD Million)
Fig. 84: UAE market, 2018-2030 (USD Million)
Fig. 85: Iran market, 2018-2030 (USD Million)
Fig. 86: Israel market, 2018-2030 (USD Million)
Fig. 87: Rest of the World market, 2018-2030 (USD Million)
Fig. 88: South Africa market, 2018-2030 (USD Million)
Fig. 2: Information procurement
Fig. 3: Primary research pattern
Fig. 4: Market research approaches
Fig. 5: Value-chain-based sizing & forecasting
Fig. 6: QFD modeling for market share assessment
Fig. 7: Market formulation & validation
Fig. 8: Commodity Flow Analysis
Fig. 9: Parent Market Analysis
Fig. 10: Healthcare CRO market snapshot (2022)
Fig. 11: Market trends and outlook
Fig. 12: Healthcare CRO market segmentation
Fig. 13: Market driver relevance analysis (Current & future impact)
Fig. 14: Benefits of using robotic labs
Fig. 15: Pharmaceutical R&D spending 2020-2022 (USD Billion)
Fig. 16: Market restraint relevance analysis (Current & future impact)
Fig. 17: Penetration & growth prospect mapping
Fig. 18: Porter’s five forces analysis
Fig. 19: SWOT analysis, by factor (political & legal, economic and technological)
Fig. 20: Healthcare CRO market stage outlook: Segment dashboard
Fig. 21: Healthcare CRO market: Type movement analysis
Fig. 22: Drug discovery market, 2018-2030 (USD Million)
Fig. 23: Target validation market, 2018-2030 (USD Million)
Fig. 24: Lead identification market, 2018-2030 (USD Million)
Fig. 25: Lead optimization market, 2018-2030 (USD Million)
Fig. 26: Pre-clinical market, 2018-2030 (USD Million)
Fig. 27: Clinical market, 2018-2030 (USD Million)
Fig. 28: Phase I trial services market, 2018-2030 (USD Million)
Fig. 29: Phase II trial services market, 2018-2030 (USD Million)
Fig. 30: Phase III trial services market, 2018-2030 (USD Million)
Fig. 31: Phase IV trial services market, 2018-2030 (USD Million)
Fig. 32: Healthcare CRO market Service outlook: Segment dashboard
Fig. 33: Healthcare CRO market: Service movement analysis
Fig. 34: Parameters for measuring success of provider solution
Fig. 35: Project management/clinical supply management market, 2018-2030 (USD Million)
Fig. 36: Clinical data management flow
Fig. 37: Data management market, 2018-2030 (USD Million)
Fig. 38: Regulatory/medical affairs market, 2018-2030 (USD Million)
Fig. 39: Medical writing market, 2018-2030 (USD Million)
Fig. 40: Clinical monitoring market, 2018-2030 (USD Million)
Fig. 41: Quality management/ assurance market, 2018-2030 (USD Million)
Fig. 42: Bio-statistics market, 2018-2030 (USD Million)
Fig. 43: Investigator payments market, 2018-2030 (USD Million)
Fig. 44: Laboratory market, 2018-2030 (USD Million)
Fig. 45: Strategic initiatives with positive impact on patient recruitment
Fig. 46: Patient and site recruitment market, 2018-2030 (USD Million)
Fig. 47: Technology services market, 2018-2030 (USD Million)
Fig. 48: Other services market, 2018-2030 (USD Million)
Fig. 49: Regional market: Key takeaways
Fig. 50: Regional outlook, 2022 & 2030
Fig. 51: North America market, 2018-2030 (USD Million)
Fig. 52: U.S. market, 2018-2030 (USD Million)
Fig. 53: Canada market, 2018-2030 (USD Million)
Fig. 54: Europe market, 2018-2030 (USD Million)
Fig. 55: UK market, 2018-2030 (USD Million)
Fig. 56: Germany market, 2018-2030 (USD Million)
Fig. 57: France market, 2018-2030 (USD Million)
Fig. 58: Italy market, 2018-2030 (USD Million)
Fig. 59: Spain market, 2018-2030 (USD Million)
Fig. 60: Switzerland market, 2018-2030 (USD Million)
Fig. 61: Belgium market, 2018-2030 (USD Million)
Fig. 62: Netherlands market, 2018-2030 (USD Million)
Fig. 63: Austria market, 2018-2030 (USD Million)
Fig. 64: Asia Pacific market, 2018-2030 (USD Million)
Fig. 65: India market, 2018-2030 (USD Million)
Fig. 66: China market, 2018-2030 (USD Million)
Fig. 67: Japan market, 2018-2030 (USD Million)
Fig. 68: South Korea market, 2018-2030 (USD Million)
Fig. 69: Taiwan market, 2018-2030 (USD Million)
Fig. 70: Australia market, 2018-2030 (USD Million)
Fig. 71: Indonesia market, 2018-2030 (USD Million)
Fig. 72: Malaysia market, 2018-2030 (USD Million)
Fig. 73: Singapore market, 2018-2030 (USD Million)
Fig. 74: Thailand market, 2018-2030 (USD Million)
Fig. 75: Latin America market, 2018-2030 (USD Million)
Fig. 76: Brazil market, 2018-2030 (USD Million)
Fig. 77: Mexico market, 2018-2030 (USD Million)
Fig. 78: Argentina market, 2018-2030 (USD Million)
Fig. 79: Colombia market, 2018-2030 (USD Million)
Fig. 80: Chile market, 2018-2030 (USD Million)
Fig. 81: Middle East & North Africa market, 2018-2030 (USD Million)
Fig. 82: Egypt market, 2018-2030 (USD Million)
Fig. 83: Saudi Arabia market, 2018-2030 (USD Million)
Fig. 84: UAE market, 2018-2030 (USD Million)
Fig. 85: Iran market, 2018-2030 (USD Million)
Fig. 86: Israel market, 2018-2030 (USD Million)
Fig. 87: Rest of the World market, 2018-2030 (USD Million)
Fig. 88: South Africa market, 2018-2030 (USD Million)
Companies Mentioned
- ICON Plc
- Charles River Laboratories
- Syneos Health
- IQVIA Inc
- GVK Biosciences Private Limited
- Laboratory Corporation of America Holdings
- Thermo Fisher Scientific Inc.
- Parexel International Corporation
- Medidata Solutions, Inc
- Pharmaron GMBH.
- SGS SA
- KCR S.A.
- CTI Clinical Trial & Consulting
- PSI
- Worldwide Clinical Trials
- Wuxi AppTec
- Advanced Clinical
- Caidya
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 175 |
| Published | June 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 44.7 Billion |
| Forecasted Market Value ( USD | $ 80.5 Billion |
| Compound Annual Growth Rate | 7.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
